Technology | Interventional Radiology | May 20, 2019

Philips Launches IntraSight Interventional Applications Platform

Platform integrates intravascular imaging and physiology applications for image-guided procedures

Philips Launches IntraSight Interventional Applications Platform

May 20, 2019 — Philips announced the launch of the new IntraSight interventional applications platform. The secure, application-based platform offers a comprehensive suite of clinically proven instant wave-free ratio (iFR), fractional flow reserve (FFR), intravascular ultrasound (IVUS) and co-registration1 modalities to simplify complex interventions and speed routine procedures.

In image-guided treatments of the heart and peripheral blood vessels, there is an increasing trend to use advanced catheters and pressure wires that are capable of producing ultrasound images of the interior of blood vessels (IVUS) and perform blood pressure measurements (FFR and iFR). There is a growing body of clinical evidence that the use of such technologies in conjunction with interventional X-ray improves patient outcomes.

“IntraSight has made an immediate impact in our lab,” said Rasha Al-Lamee, M.D., clinical academic interventional cardiology consultant at Imperial College Healthcare NHS Trust, London, U.K. “It is so simple and intuitive to use that it took us no time at all to get used to it. It has made using physiology and imaging even quicker and easier, which is a great advance for us and for our patients.”

Philips IntraSight optimizes lab performance with tableside touchscreen control, systems integration, data management and remote service diagnostics. The combination of IntraSight and Azurion, Philips’ image-guided therapy platform, provides a level of diagnostic insight and intuitive tableside control that enables clinicians to provide cardiac and peripheral vascular patients with superior care. IntraSight delivers an outstanding user experience, according to Philips. with a modern, intuitive interface that minimizes learning curves and increases workflow confidence.

Further providing seamless integration in the interventional lab, Philips SyncVision, available on IntraSight 4, advances patient care by mapping both the pressure profile and IVUS measurements of the whole vessel onto the angiogram. With iFR pullback and co-registration and IVUS co-registration1, physicians can identify the precise locations causing ischemia, plan stent length and placement with a virtual stent, and predict physiologic improvement.

iFR is a pressure-derived index proprietary to Philips, allowing a simplified hyperemia-free physiological assessment of coronary blockages. It continues to be adopted into clinical practice, with mounting evidence the technology contributes to reducing costs, improving outcomes 2, 3, 4 and enhancing the patient experience.

IntraSight will be showcased at the Society for Cardiovascular Angiography and Interventions (SCAI)scientific sessions, May 19-22 in Las Vegas, and EuroPCR, May 21-24 in Paris, France.

For more information: www.usa.philips.com/healthcare

 

References

1. Co-registration tools available within IntraSight 7 configuration via SyncVision.

2. Davies J.E., et al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017 May 11;376(19):1824-1834.

3. Gotberg M., et al. iFR Swedeheart Investigators. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017 May 11;376(19):1813-1823.

4. Patel M. “Cost-effectiveness of Instantaneous Wave-free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.

Related Content

The radiology industry is saddened to learn of the passing of another leader to COVID-19. Franklin Wilfred Sequeira, M.D., 72, of Cicero, Ind., passed away June 1, 2020. He was just short of celebrating his 40th year working with Radiology of Indiana as an interventional radiologist, never missing a day of work.

Franklin Wilfred Sequeira, M.D.

News | Coronavirus (COVID-19) | June 13, 2020
June 13, 2020 — The r
Chief among the myriad practical updates to minimize risks for patients and imaging personnel alike is a tiered approach for delaying both outpatient and inpatient cross-sectional interventional procedures

For procedural delays that will not adversely affect patient outcome, Fananapazir and colleagues proposed the following tiered approach for both outpatient and inpatient scenarios: urgent procedures, procedures that should be performed within 2 weeks, procedures that should be performed within 2 months, and procedures that can safely be delayed 2 or 6 months. Courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — An...
#gadolinium Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture Dotarem (gadoterate meglumine) injection at its Raleigh, N.C., facility
News | Interventional Radiology | April 21, 2020
April 21, 2020 — Guerbet announced that it received U.S.
SIR President Laura Findeiss, M.D., FSIR

SIR President Laura Findeiss, M.D., FSIR

News | Interventional Radiology | February 09, 2020
February 9, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 07, 2020
February 7, 2020 — An ahead-of-print...
Harel Gadot

Harel Gadot, Founder, Executive Chairman and President at XACT Robotics says their system’s small footprint and high mobility design will enable care providers to treat a broad range of patient care needs.

News | Interventional Radiology | November 01, 2019
November 1, 2019 — XACT Robotics Ltd. announced that its firs
The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

Technology | Interventional Radiology | October 28, 2019
October 28, 2019 — Office based labs (OBLs) and ambulatory surgery centers (ASCs) require a fresh perspective from im
Exact Imaging Receives FDA 510(k) Clearance for Sterile Transperineal Needle Guide
Technology | Ultrasound Imaging | October 24, 2019
Exact Imaging received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sterile Transperineal Needle...